This article is more than 5 years old. Information may no longer be current.
Roswell Park department chair receives thoracic surgery award
Click Here to Manage Email Alerts
Sai Yendamuri, MD, FACS, chair of the department of thoracic surgery at Roswell Park Cancer Institute, received the Brompton Prize from the European Society of Thoracic Surgeons.
The award recognizes the best thoracic abstract, manuscript and presentation of new research at major scientific meetings.
Yendamuri accepted the award at the society’s annual meeting, held earlier this year in Innsbruck, Austria.
The winning research assessed the impact of neoadjuvant therapy on perioperative outcomes and long-term survival among patients who underwent surgery for non-small cell lung cancer. The analysis — which included data from more than 134,000 patients in the National Cancer Data Base — showed patients who underwent neoadjuvant therapy had slightly higher 30-day and 90-day mortality. Also, neoadjuvant therapy provided no survival advantage to patients whose cancer had spread to their lymph nodes.
“In an era of increasing use of minimally invasive surgery that enables administration of adjuvant therapy more reliably, the paradigm of routine neoadjuvant therapy for patients with this stage of disease should be reconsidered,” Yendamuri said in a press release.